🔗 Share this article

The prestigious award in medical science was granted for revolutionary discoveries that illuminate how the body's defense network attacks harmful infections while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this honor.

Their research uncovered unique "sentinels" within the immune system that eliminate rogue immune cells that could attacking the organism.

These discoveries are now enabling innovative treatments for autoimmune diseases and cancer.

These winners will share a prize fund worth 11m Swedish kronor.

Crucial Findings

"Their work has been essential for understanding how the body's defenses functions and why we do not all develop severe self-attack conditions," commented the head of the Nobel Committee.

This team's research explain a core question: How does the immune system protect us from numerous invaders while leaving our own tissues intact?

Our body's protection system uses immune cells that search for indicators of infection, including viruses and germs it has not met before.

These defenders employ sensors—called receptors—that are produced randomly in a vast number of combinations.

This gives the defense network the capacity to fight a broad range of invaders, but the unpredictability of the process unavoidably produces white blood cells that can target the body.

Protectors of the Immune System

Researchers previously understood that some of these harmful defense cells were eliminated in the immune organ—where immune cells mature.

This year's Nobel Prize honors the identification of regulatory T-cells—known as the immune system's "security guards"—which travel through the body to disarm other defenders that attack the healthy cells.

We know that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

The Nobel panel added, "The findings have established a novel area of research and spurred the creation of new therapies, for example for tumors and autoimmune diseases."

Regarding cancer, regulatory T-cells block the body from attacking the tumor, so studies are focused on reducing their quantity.

In self-attack disorders, trials are exploring boosting regulatory T-cells so the body is not under attack. A comparable method could also be effective in minimizing the risks of transplanted organ rejection.

Pioneering Studies

Prof Shimon Sakaguchi, from Osaka University, conducted experiments on mice that had their immune gland extracted, causing self-attack conditions.

He showed that introducing defense cells from healthy animals could stop the illness—implying there was a mechanism for blocking immune cells from harming the host.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited autoimmune disease in rodents and humans that resulted in the identification of a gene vital for how regulatory T-cells function.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly attacking the healthy cells," commented a prominent biological science expert.

"The research is a striking example of how fundamental biological research can have broad consequences for public health."